CASE REPORT
Published on 02 May 2025
Venetoclax combined with ATRA shows promising therapeutic potential for TFG:: RARA variant APL: a case report
doi 10.3389/fonc.2025.1529640
- 794 views
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- Combination Therapies in Acute Myeloid Leukemia (AML)
Combination Therapies in Acute Myeloid Leukemia (AML)
1,582
Total downloads
8,619
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
CLINICAL TRIAL
Published on 17 Apr 2025
Updates from a single-center phase 2 study of PD-1 inhibitor combined with hypomethylating agent plus CAG regimen in patients with relapsed/refractory acute myeloid leukemia
doi 10.3389/fimmu.2025.1533467
- 1,408 views
ORIGINAL RESEARCH
Published on 31 Mar 2025
The association of FAT1 mutations with therapeutic outcomes in AML, especially in receiving venetoclax combination
doi 10.3389/fonc.2025.1456832
- 1,007 views
CASE REPORT
Published on 27 Mar 2025
Case Report: Decitabine and venetoclax sequentially followed by FLAG-Ida and venetoclax with immediate allogeneic stem cell transplantation in newly diagnosed acute myeloid leukemia with chromosome 3 inversion/MECOM rearrangement
doi 10.3389/fonc.2025.1530852
- 1,828 views
CLINICAL TRIAL
Published on 26 Feb 2025
Phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in older patients with newly diagnosed acute myeloid leukemia
doi 10.3389/fimmu.2025.1525110
- 1,662 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.